Emerging Treatments in Acute Lymphoblastic Leukemia
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
19-31
Author(s):
R. Crazzolara and L. Bendall
The Changing Face of HDAC Inhibitor Depsipeptide
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
91-100
Author(s):
Wen Zhou and Wei-Guo Zhu
Targeted Tumor Therapies at a Glance
Journal:
Current Drug Targets
Volume:
10
Page:
89-93
Author(s):
H. Fuchs and C. Bachran
Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
Journal:
Current Drug Targets
Volume:
10
Page:
94-103
Author(s):
E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich
Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Journal:
Current Drug Targets
Volume:
10
Page:
158-175
Author(s):
P. M. Deckert
Methotrexate Induced Pneumonitis: A Review Article
Journal:
Current Respiratory Medicine Reviews
Volume:
5
Page:
12-20
Author(s):
Batsi Chikura, Navtej Sathi and Julie K. Dawson
Role of Active Drug Transporters in Refractory Multiple Myeloma
Journal:
Current Topics in Medicinal Chemistry
Volume:
9
Page:
218-224
Author(s):
Marco Tucci, Cosima Quatraro, Franco Dammacco and Franco Silvestris
Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Journal:
Current Pediatric Reviews
Volume:
5
Page:
36-51
Author(s):
Rodney R. Dietert and Judith T. Zelikoff
Targeted Drugs and Nanomedicine: Present and Future
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
153-172
Author(s):
Paul Debbage
Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
Journal:
Current Drug Targets
Volume:
10
Page:
26-37
Author(s):
Ewa Robak and Tadeusz Robak